Cancer testis antigen and interleukin expression correlates with survival in small bowel neuroendocrine tumors

Authors

Y David Seo, The University of Texas MD Anderson Cancer Center
Russell G. Witt, The University of Texas MD Anderson Cancer Center
Samuel Cass, The University of Texas MD Anderson Cancer Center
Rossana Lazcano, The University of Texas MD Anderson Cancer Center
Courtney Hudgens, The University of Texas MD Anderson Cancer Center
Khalida Wani, The University of Texas MD Anderson Cancer Center
Sharia Hernandez, The University of Texas MD Anderson Cancer Center
Daniel Halperin, The University of Texas MD Anderson Cancer Center
Alexander Lazar, The University of Texas MD Anderson Cancer Center
Jennifer Wargo, The University of Texas MD Anderson Cancer Center
Jeannelyn S. Estrella, The University of Texas MD Anderson Cancer Center
Jessica E. Maxwell, The University of Texas MD Anderson Cancer Center

Files

Abstract

View full abstract

DOI

https://doi.org/10.52519/00084

Publication Date

2022

Department

Surgical Oncology

Research Category

Unleashing the Immune System to Develop Therapeutic Strategies

Recommended Citation

Seo, Y David; Witt, Russell G.; Cass, Samuel; Lazcano, Rossana; Hudgens, Courtney; Wani, Khalida; Hernandez, Sharia; Halperin, Daniel; Lazar, Alexander; Wargo, Jennifer; Estrella, Jeannelyn S.; and Maxwell, Jessica E., "Cancer testis antigen and interleukin expression correlates with survival in small bowel neuroendocrine tumors" (2022). Leading Edge of Cancer Research Symposium. 43.
doi:https://doi.org/10.52519/00084